Brooks A L, Benjamin S A, Hahn F F, Brownstein D G, Griffith W C, McClellan R O
Radiat Res. 1983 Oct;96(1):135-51.
The influence of radiation dose distribution on the frequency of 239Pu-induced liver tumors was evaluated in the Chinese hamster. Different concentrations of 239Pu citrate 239PuO2 particles of known sizes were injected intravenously via the jugular vein. About 60% of the injected 239Pu citrate was deposited in the liver and 40% in the bone. The 239Pu citrate was rather uniformly distributed throughout the liver parenchyma. Injected plutonium oxide particles were taken up by the reticuloendothelial system with 90% of the body burden deposited in the liver. The 239PuO2 particles were localized in the Kupffer cells and produced nonuniform dose distributions that were dependent on particle size. There was an activity- and dose-dependent increase in the incidence of total liver parenchymal cell tumors following injection with either plutonium particles or citrate. For animals that received 14.0-, 2.7-, 0.3-, and 0.04-Gy dose to liver from 239Pu citrate the cumulative tumor incidence was 39, 32, 5, and 0%, respectively. Animals that were injected with the 0.24 micron 239PuO2 particles had doses of 42.0, 7.2, and 0.8 Gy to the liver and tumor incidences of 34, 26, and 5%, respectively. Plutonium citrate also produced hemangiosarcomas of the liver and tumors in bone and bone marrow. The latent period for liver tumor appearance in animals exposed to 239Pu citrate or 239PuO2 particles increased as the injected activity decreased. For animals injected with a similar total activity (7.4 Bq/g), the lifetime cumulative liver tumor incidence was similar for animals exposed to either 239Pu citrate (32%) or 239PuO2 (26%). There was little effect of particle size on liver tumor incidence. These data indicate that, in Chinese hamster liver, local radiation dose distribution is less important in altering tumor incidence than injected activity or average dose. However, the more uniform irradiation from 239Pu citrate administration was more effective in cancer production than the nonuniform irradiation from 239PuO2 particles.
在中国仓鼠中评估了辐射剂量分布对239Pu诱发肝肿瘤频率的影响。通过颈静脉静脉注射不同浓度的已知大小的239Pu柠檬酸盐和239PuO2颗粒。注入的239Pu柠檬酸盐约60%沉积在肝脏中,40%沉积在骨骼中。239Pu柠檬酸盐在整个肝实质中分布相当均匀。注入的氧化钚颗粒被网状内皮系统摄取,90%的体内负荷沉积在肝脏中。239PuO2颗粒定位于库普弗细胞中,并产生取决于颗粒大小的不均匀剂量分布。注射钚颗粒或柠檬酸盐后,肝实质细胞肿瘤的总发生率呈活性和剂量依赖性增加。对于接受来自239Pu柠檬酸盐的肝脏剂量为14.0、2.7、0.3和0.04 Gy的动物,累积肿瘤发生率分别为39%、32%、5%和0%。注射0.24微米239PuO2颗粒的动物肝脏剂量分别为42.0、7.2和0.8 Gy,肿瘤发生率分别为34%、26%和5%。柠檬酸盐钚还会产生肝血管肉瘤以及骨骼和骨髓中的肿瘤。暴露于239Pu柠檬酸盐或239PuO2颗粒的动物出现肝肿瘤的潜伏期随着注入活性的降低而增加。对于注射了相似总活性(7.4 Bq/g)的动物,暴露于239Pu柠檬酸盐(32%)或239PuO2(26%)的动物终生累积肝肿瘤发生率相似。颗粒大小对肝肿瘤发生率影响很小。这些数据表明,在中国仓鼠肝脏中,局部辐射剂量分布在改变肿瘤发生率方面不如注入活性或平均剂量重要。然而,239Pu柠檬酸盐给药产生的更均匀照射在致癌方面比239PuO2颗粒产生的不均匀照射更有效。